Labeler · US market

Jaymac Pharmaceuticals, LLC

Jaymac Pharmaceuticals, LLC is a US drug labeler with US FDA registrations covering 2 drug concepts (2 currently active) across 2 packages. It is currently the only active US supplier of 2 drugs. The company files with FDA under 2 name variants, merged into this profile.

Also files as: Jaymac Pharmaceuticals

ACTIVE — US

openFDA · updated weekly

Labeler codes64661

Active drugs2

Registrations2 active / 2

Packages2

Sole supplier of2 drugs

Portfolio2 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Levomefolate Magnesium, Leucovorin, Folic Acid, Ferrous Cysteine Glycinate, Magnesium Ascorbate, Zinc Ascorbate, Cocarboxylase, Flavin Adenine Dinucleotide, Nadh, Pyridoxal Phosphate Anhydrous, Cobamamide, Betaine, Magnesium L-Threonate, 1,2-Docosahexanoyl-Sn-Glycero-3-Phosphoserine Calcium, 1,2-Icosapentoyl-Sn-Glycero-3-Phosphoserine Calcium, And Phosphatidyl Serine capsule, delayed release pellets	rx	1	1	SUPPLYING
Leucovorin, Folic Acid, Levomefolate Magnesium, Ferrous Cysteine Glycinate, 1,2-Docosahexanoyl-Sn-Glycero-3-Phosphoserine Calcium, 1,2-Icosapentoyl-Sn-Glycero-3-Phosphoserine Calcium, Phosphatidyl Serine, Pyridoxal 5-Phosphate, Flavin Adenine Dinucleotide, Nadh, Cobamamide, Cocarboxylase (Thiamine Pyrophosphate), Magnesium Ascorbate, Zinc Ascorbate, Magnesium L-Threonate And Betaine Capsule capsule	rx	1	1	SUPPLYING

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

At a glance

TypeLabeler
Labeler codes64661
Filing names2
Drugs (active)2
Drugs (all time)2
US registrations2
Packages2

Recent events

Shortages, recalls, and registration changes across all filing names.

Dec 16, 2014
RECALLRecall (Class II): J-TAN D PD Drops (bromphenirame maleate 1 mg and pseudoephedrine hcl 7.5 mg/ teaspoon), 1 fl oz (30 mL) Bottle, Over th…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile (see “Also files as” above); figures cover the entity across all its filing names.